Previous studies have shown that the m6A RNA methylase METTL3 promotes glioma progression by stabilizing the expression of SOX2, suggesting an important role of m6A modifications in glioma (Somasundaram, 2018; Visvanathan et al., 2018). The gene discussed is SOX2; the disease is glioma.